An observational study in Uremia and End Stage Renal Disease on Dialysis, sponsored by RenJi Hospital. Completed. Per ClinicalTrials.gov, last updated 2025-07-25.
Sponsored by RenJi Hospital · Observational
It was VAT volume predict patient outcome, while VAT density predicted baseline membrane function in PD patients and reflected peritoneal vascular density and local inflammation status.
53 studies on the registry are indexed under Uremia; 10 are open to participants now.
This study's enrollment of 358 is above the median of 105 across 12 observational studies indexed under Uremia.
Browse Uremia studies →RenJi Hospital is the lead sponsor of 550 studies on the registry; 247 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study included peritoneal dialysis patients follow up in our center who had an abdominal CT scan within 2 weeks before PD catheter incubation. Those with acute inflammation according to clinical signs, lab results or abdominal CT scan were excluded from the cohort. In early years, abdominal CT scan was done if the patient reported history of abdominal abnormalities, such as history of cholelithiasis. Since 2020 it became a routine check before PD catheter incubation in our center. Those with cholelithiasis or hernia were suggested to had the preventive operation at the time of PD catheter incubation under general anesthesia. The patients started PD within 4 weeks after catheter incubation. A validation cohort was from a satellite center of the hospital. The inclusion criteria were same as the derivation cohort.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
To evaluate the association between peritoneal membrane solute transfer rate and abdominal visceral adipose tissue density measured on CT
Time frame: from the baseline, 4 weeks before PD catheter insert surgery until patients quit PD or follow up up to 48 months
No study locations are listed for this record.
Ran from Jul 2015 to primary completion in Jul 2023, 95 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.